Daniel Cohen

Daniel Cohen is the Executive Medical Director of Clinical Development at AbbVie, specializing in cystic fibrosis, idiopathic pulmonary fibrosis, and therapeutic toxins. Prior to this, they held various roles at AbbVie, including Global Development Lead and Group Medical Director for antiviral drug development, and served as Medical Director at Abbott Laboratories. Daniel's earlier experience includes positions as Associate Medical Director of Research at Fenway Community Health, where they also engaged in academia as an instructor at Harvard Medical School. They hold a Doctor of Medicine degree from The University of Connecticut School of Medicine and completed an Infectious Disease Fellowship at Northwestern University.